Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 10, 2014, after the close
10-Q filed Nov 10, 2014, 41 days after period end · 0001193125-14-406106
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $15.00K | $240.00K | $3.48M | $584.00K |
| Net Income | -$24.79M | -$10.70M | -$2.40M | -$5.08M |
| EPS Diluted | -$0.25 |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.12 |
| -$0.04 |
| -$0.10 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
